Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer-Reference-Cited by-同舟云学术

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer

Published:2019-01-15 Issue:1 Volume:11 Page:17-27
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:
Short-container-title:WJGO

Author:

Suenaga Yasuhito,Kanda Mitsuro,Ito Seiji,Mochizuki Yoshinari,Teramoto Hitoshi,Ishigure Kiyoshi,Murai Toshifumi,Asada Takahiro,Ishiyama Akiharu,Matsushita Hidenobu,Tanaka Chie,Kobayashi Daisuke,Fujiwara Michitaka,Murotani Kenta,Kodera Yasuhiro

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference36 articles.

1. Gastric cancer

2. Gastric cancer—molecular and clinical dimensions

3. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer

4. Updated evidence on adjuvant treatments for gastric cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value and predictive model of tumor markers in stage I to III gastric cancer patients;World Journal of Clinical Oncology;2024-08-24

2. Role of CYFRA 21-1 and CEA as prognostic and predictive markers in locally advanced and metastatic gastric carcinoma;Journal of Cancer Research and Therapeutics;2024-01-22

3. Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study;Japanese Journal of Clinical Oncology;2024-01-20

4. A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study;European Journal of Surgical Oncology;2023-11

5. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer;Cancers;2023-10-29